RIPK4 Is an Immune Regulating-Associated Biomarker for Ovarian Cancer and Possesses Generalization Value in Pan-Cancer

Figure 2

(a) Kaplan-Meier curves for the OS of patients in the high RIPK4 expression group and low RIPK4 expression group in OC patients. (b) The ROC curves represented the discrimination of the models measured by the C-index.

(a)

(b)